Telehealth & Digital Health

A new high-tech wellness center arrives in Boulder, offering cutting-edge services. But does the science support the high price of proactive health?

Facing a cancer diagnosis is overwhelming. Manulife's new Cancer Coach program offers a lifeline with personalized support for daily life and work.

American Specialty Health's entire coaching team is now NBHWC-certified, a move setting a new quality benchmark in the booming digital health market.

Experic and Flurry Powders form a strategic alliance to accelerate complex therapies by combining advanced particle engineering with GMP manufacturing.

GuideWell's 2025 Impact Report details a multi-pronged strategy using AI, community investment, and value-based care to tackle healthcare costs.

Cipla Health launches a Masala Guava flavored ORS, targeting India's daily wellness market by turning a medical staple into an enjoyable hydration choice.

A new Phase 2 trial is testing an inhaled version of a key IPF drug, aiming to reduce severe side effects and transform treatment for the fatal lung disease.

New research reveals a startling link between common liver conditions and heart failure in older adults with atrial fibrillation, urging a new look at risk.

Telehealth platforms like ReflexMD offer cheaper, compounded GLP-1s for weight loss. But what are the risks, and what do consumers need to know?

With a history of billion-dollar deals, Mark Altmeyer takes the helm at ReproNovo, aiming to commercialize its promising fertility and women's health pipeline.

The University of Miami launches a new program to arm doctors with business skills, addressing a critical leadership gap in the evolving healthcare industry.

A new oral drug is being tested with existing therapies, offering a two-pronged attack on the glycogen buildup that defines this debilitating rare disease.

A novel blood test from C2N Diagnostics, used in a major Alzheimer's trial, shows promise in predicting disease progression, heralding a new era of precision medicine.

With a new CFO who helped steer a multi-billion dollar acquisition, Bambusa Therapeutics signals major growth plans for its innovative antibody platform.

As its new obesity drug enters a key trial, Biohaven bets on a novel approach: reducing fat while preserving precious muscle mass. Can it redefine weight loss?

A new DoD-funded trial combines a biologic drug with a plant-based supplement, aiming to break treatment barriers for ulcerative colitis, a major military issue.

AAPACN's 2026 awards honor leaders whose expertise and innovation are driving measurable improvements in resident outcomes and tackling industry-wide challenges.

A new partnership signals a major shift in the aesthetics market, blending private equity scale with a new focus on university-backed provider education.

With fresh funding secured, Dogwood Therapeutics pushes its promising nerve pain drug, Halneuron®, toward a pivotal data readout later this year.

JenaValve's Trilogy system gains historic FDA approval, offering a new, minimally invasive option for high-risk patients with a life-threatening heart condition.